Blog
Join our newsletter
Stay up to date with EpiVax and greater industry news, events, and technological advancements with this monthly update.
ISPRI for Bi-Specifics? Yes, we Can!
ISPRI for Bi-Specifics? Yes, we Can! ...
Where will we meet you in 2024?
Where will we meet you in 2024?...
FDA Request for “Integrated Summary of Immunogenicity”
FDA Request for "Integrated Summary of...
How AI + HI Are Transforming Vaccine Development (and Why We’re Grateful for You)
This is a two-way street Hey Hey, Hallo, Hola,...
Fearless Truth in Biotechnology
Amsterdam Immunogenicity and Tolerance Seminar:...
Dreaming of Peptides
Welcome to Tokyo! Yes, it’s true — EpiVax is in...
Peptide Drug Immunogenicity: PANDA Guidelines and What Retatrutide Might Be Missing
Immunogenicity Assessment of Peptide Drugs:...
AI Meets Animal Health: Smarter Vaccine Design with EpiCC™ and Human Insight
AI Meets Animal Health: Smarter Vaccine Design...
25 years of Fearless Science and… EpiVax 2.0!
25 years of Fearless Science In case you hadn't...